KVKelvin Voon

Kelvin Voon

*This is an algorithmically generated author record based on publicly available information.

Kelvin Voon has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Total Small Bowel Length and Limb-length Decision-making in Metabolic and Bariatric Surgery for Asian Populations: An APMBSS 2026 Modified Delphi Expert Consensus Statement

    by Ting-Wei Chang, Asim Shabbir, Abhishek Katakwar, Choon Woon Ngo, Aung Myint Oo, Errawan Ramawitana Wiradisuria, Ghulam Siddiq, Halit Eren Taşkın, Haris Khwaja, Huilin Koh, et al.

    Introduction Total small bowel length (TSBL) varies substantially and may modify the physiological effect of intestinal bypass in metabolic and bariatric surgery (MBS). Fixed limb lengths do not account for individual variation and may contribute to suboptimal metabolic effect or excessive malabsorption. Methods The APMBSS 2026 TSBL Consensus Panel used a two-round modified Delphi process. Faculty rated 38 statements across seven domains on a 5-point Likert scale. Thirty-five statements reached consensus in Round 1 and were reaffirmed during faculty review at the congress without repeat scoring; only three were revised and revoted. Consensus required a median score of at least 4 and at least 80% of ratings at 4 or 5; strong consensus required at least 90% agreement. Results Forty-one analyzable responses from 15 countries/regions were included in Round 1. Thirty-five statements reached consensus. Three statements were discussed, revised, and revoted; one additional statement reached consensus. Overall, 36 of 38 statements achieved consensus (30 strong, 6 consensus). No final consensus was reached on routine TSBL measurement during standard sleeve gastrectomy or on diminishing metabolic returns beyond a 150-cm biliopancreatic limb in Roux-en-Y gastric bypass. Conclusion The consensus supports standardized measurement and documentation of TSBL and procedure-specific limb lengths in bypass-based procedures. It does not prescribe a universal limb-length formula, but establishes a framework for interpreting bypass physiology, balancing metabolic efficacy and nutritional safety, and evaluating TSBL-adjusted strategies in Asian registries and prospective studies. Key Points • TSBL provides an anatomical denominator for interpreting intestinal bypass. • Standardized TSBL and limb-length documentation was supported by the panel. • No universal TSBL-adjusted limb-length formula was supported. • The panel supported a minimum 300-cm common channel for SADI-S in Asian populations.

  • Open Access

    Predictors of readmission after esophagectomy for esophageal cancer: a systematic review and meta-analysis

    by Seng Pei Khaw, Hassan Jabar, Yan Bin Fong, Martin Tze Wah Kueh, Kartik Saxena, Seong Hong Tan, Kelvin Voon

    Introduction: Esophageal cancer represents a major global health challenge. Multimodality treatment, involving esophagectomy with chemotherapy, radiotherapy, or immunotherapy, remains the standard of care for locally advanced esophageal cancers. Objectives: Unplanned hospital readmission has emerged as a key indicator of surgical quality and long-term patient outcomes after esophageal cancer surgery. This meta-analysis aims to provide a comprehensive review of predictors of unplanned readmission following esophagectomy. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. A literature search for studies reporting readmission following esophagectomy up to November 2024 was conducted for PubMed and Embase. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported for the risk factors in question. Random-effects meta-analysis models were applied accordingly. Results: A total of 43 studies with 164 948 participants were included, with a pooled readmission rate of 16.4%. Comorbidities, particularly diabetes mellitus, chronic obstructive pulmonary disease, and cardiovascular disease, were associated with increased risk of readmission. A higher risk of readmission was also observed among women [OR 1.12 (95% CI 1.02, 1.23) P = 0.02]. Both higher American Society of Anesthesiologists (ASA) (III/IV) and longer length of index stay (>10 days) were important indicators of higher readmission rates [OR 2.27 (1.05, 4.89), P < 0.004] and [OR 1.35 (1.14, 1.61), P < 0.0007]. In contrast, neoadjuvant therapy was a protective factor for readmission [0.74 (95% CI 0.59, 0.92) P = 0.008]. Postoperative complications, especially anastomotic leak, wound-related, pulmonary, and thromboembolic events, were associated with readmission. Readmission was not significantly associated with mortality [OR 1.65 (95% CI 0.82, 3.33), P = 0.16]. Conclusion: This review provides a comprehensive overview of readmission after esophageal cancer surgery, a major indicator fof quality care. Our findings identified several potential risk factors of readmission following esophagectomy. These included comorbidities, ASA III/IV status, postoperative complications, and prolonged hospital stay. Neoadjuvant therapy may have potential benefits on unplanned readmission. By identifying modifiable risk factors, future optimization of health outcomes and preventive measures can be achieved.